# BIVALIRUDIN

NDC: 55150-210
Generic name: BIVALIRUDIN
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180727

FDA application: ANDA205962

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e574d04f-67b4-4a84-9d66-8c2d54f95120